Drug Trial Radar · NCT05071612
Parallel Arm Trial of AD109 and AD504 In Patients With OSA
Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
294
Actual
Start
Nov 29, 2021
Primary completion
Jul 20, 2022
Study completion Aug 3, 2022
Sponsor
- Lead sponsor
- ApnimedIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2 randomized double-blind placebo-controlled parallel-arm dose finding study to compare fixed dose combinations of AD109 and AD504 to atomoxetine or placebo in Obstructive Sleep Apnea.
Conditions
- OSA - Obstructive Sleep Apnea
Interventions
AD109Drug
Oral administration at bedtime
AD504Drug
Oral administration at bedtime
Atomoxetine HydrochlorideDrug
Oral administration at bedtime
PlaceboDrug
Oral administration at bedtime
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Apnea-Hypopnea Index (AHI4) From Baseline: Combined AD109 Arms vs. PlaceboTime frame: Baseline (mean of PSG Visits 2 and 3) to Day 21 and Day 28 (PSG Visits 5 and 6)
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Santa Monica Clinical Trials
Los Angeles, California
Pacific Research Network
San Diego, California
SDS Clinical Trials, Inc.
Santa Ana, California
Delta Waves
Colorado Springs, Colorado
Teradan Clinical Trials
Brandon, Florida
Research Centers of America -- Hollywood
Hollywood, Florida
Sleep Medicine Specialists of South Florida
Miami, Florida
NeuroTrials Research, Inc.
Atlanta, Georgia
Chicago Research Center
Chicago, Illinois
The Center for Sleep & Wake Disorders
Chevy Chase, Maryland
Sleep Disorders Centers of the Mid-Atlantic (SDCMA)
Glen Burnie, Maryland
Neurocare
Newton, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Sleep and Attention Disorders Institute
Sterling Heights, Michigan
Minnesota Lung Center / Minnesota Sleep Institute
Woodbury, Minnesota
St. Luke's Hospital Sleep Medicine
Chesterfield, Missouri
Clayton Sleep Institute
Maplewood, Missouri
Clinilabs
New York, New York
Coastal Carolina Health Care, P.A.
New Bern, North Carolina
CTI Clinical Research Center
Cincinnati, Ohio
Intrepid Research
Cincinnati, Ohio
Brian Abaluck, LLC
Malvern, Pennsylvania
Bogan Sleep Consultants LLC
Columbia, South Carolina
Velocity Clinical Research
Greenville, South Carolina
FutureSearch Trials of Neurology
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.